secwatch.observer — SEC 8-K summary
======================================

Issuer:     Guardant Health, Inc. (GH)
CIK:        0001576280
Form:       8-K
Filed at:   2022-02-28T23:59:59+00:00
Accession:  0001193125-22-058240
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Guardant Health director Meresman to leave board; governance reforms adopted
----------------------------------------------------------------------------

- Stanley Meresman, a Class I director, will not stand for re-election at June 2022 annual meeting; no disagreement.
- Board expanded from 7 to 9 directors, now includes 4 women.
- Nominating Committee charter amended to oversee ESG, ethical compliance, IT healthcare regulatory compliance.
- Code of Conduct updated with broader standards on conflicts, antitrust, political contributions, social media.
- Committee assignments effective May 1, 2022: Audit (Meresman), Compensation (Gadde), Nominating (Clark).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1576280/000119312522058240/0001193125-22-058240-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1576280/000119312522058240/d203874d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-058240

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer